Vav proteins control MyD88-dependent oxidative burst
Ana V. Miletic(University of Zagreb), Wojciech Swat(Silicon Labs (United States)), Daniel B. Graham(Broad Institute), Vivianne Montgrain(Washington University in St. Louis), Ramnik J. Xavier(Massachusetts General Hospital), Tracie Kloeppel(Washington University in St. Louis), Robert D. Schreiber(Parker Institute for Cancer Immunotherapy), Karry Brim(Washington University in St. Louis), Keiko Fujikawa(Sapporo University), Brian K. Weaver(Washington University in St. Louis)
Cited by 83
Related Papers
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Defining trained immunity and its role in health and disease
|Nature reviews. Immunology|2020|2.5k